[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fVAkAv-rlumRDWKevoRSTxYOcp4u-kor0w7syO3pY16g":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":84,"rows":91},"Murdoch Childrens Research Institute",[4],90,false,34,15,199930,27,42,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"COVID-19",9,{"name":18,"count":19},"Sepsis",4,{"name":21,"count":19},"Infection",{"name":23,"count":24},"Allergy",3,{"name":26,"count":24},"Dermatitis, Atopic",{"name":28,"count":24},"Cellulitis",{"name":30,"count":24},"Respiratory Tract Infections",{"name":32,"count":24},"Bacteremia",[34,39,44,49,54,59,64,69,74,79],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05658523","COVID-19 Booster Study in Healthy Adults in Australia","2024-10-13","Bivalent Moderna",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT03089905","A Study to Compare the Long-term Outcomes After Two Different Anaesthetics","2026-03","Sevoflurane",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06186141","Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone","2026-03-19","Morphine",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT05500326","Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)","2026-06","Ivermectin",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06383338","A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.","2026-07","Omeprazole",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05615389","Pilot Study of MC in Paediatric Palliative Care","2026-10","Medicinal Cannabis - C12T12",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT04538053","BonE and Joint Infections - Simplifying Treatment in Children Trial","2026-12","Oral cefalexin only",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT05983159","A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations","2027-01","Alpelisib",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT06529536","Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.","2027-08","Tacrolimus",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT02112734","Can Vitamin D Supplementation in the First Year of Life Prevent Food Allergy in Infants? The VITALITY Trial: Parts 1&2","2028-04","Vitamin D",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,120,138,161,179,202,232,250,268,286,304,331,349,371,410,432,467,485,503,525,547,565,590,608,648,666,688,706,735,764,782,800,818,849,867,890,915,940,958,976,1006,1024,1042,1060,1078,1096,1132,1154,1182,1209,1227,1245,1270,1297,1315,1341,1367,1385,1410,1436,1454,1472,1501,1519,1537,1555,1573,1591,1624,1647,1672,1699,1724,1749,1776,1802,1828,1846,1873,1902,1920,1943,1969,1987],{"intervention":68,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":118},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":67},[106],{"nctId":65,"briefTitle":66,"status":107,"phases":108,"primaryCompletion":67,"completion":67,"start":109,"enrollment":110,"conditions":111,"interventions":116},"RECRUITING",[89],"2021-06-01",285,[112,113,114,115],"Bone Infection","Septic Arthritis","Bone and Joint Infection","Osteomyelitis",[68,117],"IV cefazolin or IV flucloxacillin followed by oral cefalexin",{"trials":119,"activeCount":97},[],{"intervention":117,"totalTrials":93,"cells":121},{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":136},{"trials":123,"activeCount":97},[],{"trials":125,"activeCount":97},[],{"trials":127,"activeCount":97},[],{"trials":129,"activeCount":97},[],{"trials":131,"activeCount":93,"soonestReadout":67},[132],{"nctId":65,"briefTitle":66,"status":107,"phases":133,"primaryCompletion":67,"completion":67,"start":109,"enrollment":110,"conditions":134,"interventions":135},[89],[112,113,114,115],[68,117],{"trials":137,"activeCount":97},[],{"intervention":48,"totalTrials":93,"cells":139},{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":159},{"trials":141,"activeCount":97},[],{"trials":143,"activeCount":97},[],{"trials":145,"activeCount":97},[],{"trials":147,"activeCount":97},[],{"trials":149,"activeCount":93,"soonestReadout":47},[150],{"nctId":45,"briefTitle":46,"status":107,"phases":151,"primaryCompletion":47,"completion":152,"start":153,"enrollment":154,"conditions":155,"interventions":157},[89],"2027-03-19","2024-03-13",690,[156],"Patient-Controlled Analgesia",[48,158],"Oxycodone",{"trials":160,"activeCount":97},[],{"intervention":158,"totalTrials":93,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":171,"NA":177},{"trials":164,"activeCount":97},[],{"trials":166,"activeCount":97},[],{"trials":168,"activeCount":97},[],{"trials":170,"activeCount":97},[],{"trials":172,"activeCount":93,"soonestReadout":47},[173],{"nctId":45,"briefTitle":46,"status":107,"phases":174,"primaryCompletion":47,"completion":152,"start":153,"enrollment":154,"conditions":175,"interventions":176},[89],[156],[48,158],{"trials":178,"activeCount":97},[],{"intervention":83,"totalTrials":93,"cells":180},{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":200},{"trials":182,"activeCount":97},[],{"trials":184,"activeCount":97},[],{"trials":186,"activeCount":97},[],{"trials":188,"activeCount":97},[],{"trials":190,"activeCount":93,"soonestReadout":82},[191],{"nctId":80,"briefTitle":81,"status":192,"phases":193,"primaryCompletion":82,"completion":194,"start":195,"enrollment":196,"conditions":197,"interventions":199},"ACTIVE_NOT_RECRUITING",[89],"2028-12","2014-12",2739,[198],"Food Allergy",[83],{"trials":201,"activeCount":97},[],{"intervention":203,"totalTrials":93,"cells":204},"Benzylpenicillin - single dose",{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":213,"NA":230},{"trials":206,"activeCount":97},[],{"trials":208,"activeCount":97},[],{"trials":210,"activeCount":97},[],{"trials":212,"activeCount":97},[],{"trials":214,"activeCount":93,"soonestReadout":219},[215],{"nctId":216,"briefTitle":217,"status":107,"phases":218,"primaryCompletion":219,"completion":219,"start":220,"enrollment":221,"conditions":222,"interventions":225},"NCT04876131","Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children",[89],"2028-05-16","2022-05-30",452,[223,21,224],"Complicated Urinary Tract Infection","Pediatric Infectious Disease",[203,226,227,228,229],"Benzylpenicillin - three days","Gentamicin - single dose","Gentamicin - three days","Cefalexin - post single dose of IV antibiotics for the remaining two days",{"trials":231,"activeCount":97},[],{"intervention":226,"totalTrials":93,"cells":233},{"EARLY_PHASE1":234,"PHASE1":236,"PHASE2":238,"PHASE3":240,"PHASE4":242,"NA":248},{"trials":235,"activeCount":97},[],{"trials":237,"activeCount":97},[],{"trials":239,"activeCount":97},[],{"trials":241,"activeCount":97},[],{"trials":243,"activeCount":93,"soonestReadout":219},[244],{"nctId":216,"briefTitle":217,"status":107,"phases":245,"primaryCompletion":219,"completion":219,"start":220,"enrollment":221,"conditions":246,"interventions":247},[89],[223,21,224],[203,226,227,228,229],{"trials":249,"activeCount":97},[],{"intervention":227,"totalTrials":93,"cells":251},{"EARLY_PHASE1":252,"PHASE1":254,"PHASE2":256,"PHASE3":258,"PHASE4":260,"NA":266},{"trials":253,"activeCount":97},[],{"trials":255,"activeCount":97},[],{"trials":257,"activeCount":97},[],{"trials":259,"activeCount":97},[],{"trials":261,"activeCount":93,"soonestReadout":219},[262],{"nctId":216,"briefTitle":217,"status":107,"phases":263,"primaryCompletion":219,"completion":219,"start":220,"enrollment":221,"conditions":264,"interventions":265},[89],[223,21,224],[203,226,227,228,229],{"trials":267,"activeCount":97},[],{"intervention":228,"totalTrials":93,"cells":269},{"EARLY_PHASE1":270,"PHASE1":272,"PHASE2":274,"PHASE3":276,"PHASE4":278,"NA":284},{"trials":271,"activeCount":97},[],{"trials":273,"activeCount":97},[],{"trials":275,"activeCount":97},[],{"trials":277,"activeCount":97},[],{"trials":279,"activeCount":93,"soonestReadout":219},[280],{"nctId":216,"briefTitle":217,"status":107,"phases":281,"primaryCompletion":219,"completion":219,"start":220,"enrollment":221,"conditions":282,"interventions":283},[89],[223,21,224],[203,226,227,228,229],{"trials":285,"activeCount":97},[],{"intervention":229,"totalTrials":93,"cells":287},{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":302},{"trials":289,"activeCount":97},[],{"trials":291,"activeCount":97},[],{"trials":293,"activeCount":97},[],{"trials":295,"activeCount":97},[],{"trials":297,"activeCount":93,"soonestReadout":219},[298],{"nctId":216,"briefTitle":217,"status":107,"phases":299,"primaryCompletion":219,"completion":219,"start":220,"enrollment":221,"conditions":300,"interventions":301},[89],[223,21,224],[203,226,227,228,229],{"trials":303,"activeCount":97},[],{"intervention":305,"totalTrials":93,"cells":306},"Antibiotics for duration of symptoms",{"EARLY_PHASE1":307,"PHASE1":309,"PHASE2":311,"PHASE3":313,"PHASE4":315,"NA":329},{"trials":308,"activeCount":97},[],{"trials":310,"activeCount":97},[],{"trials":312,"activeCount":97},[],{"trials":314,"activeCount":97},[],{"trials":316,"activeCount":93,"soonestReadout":322},[317],{"nctId":318,"briefTitle":319,"status":320,"phases":321,"primaryCompletion":322,"completion":322,"start":52,"enrollment":323,"conditions":324,"interventions":327},"NCT07532941","Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'","NOT_YET_RECRUITING",[89],"2028-06",200,[325,28,30,326],"Urinary Tract Infection","Lymphadenitis",[305,328],"Antibiotics for duration of prescribed course",{"trials":330,"activeCount":97},[],{"intervention":328,"totalTrials":93,"cells":332},{"EARLY_PHASE1":333,"PHASE1":335,"PHASE2":337,"PHASE3":339,"PHASE4":341,"NA":347},{"trials":334,"activeCount":97},[],{"trials":336,"activeCount":97},[],{"trials":338,"activeCount":97},[],{"trials":340,"activeCount":97},[],{"trials":342,"activeCount":93,"soonestReadout":322},[343],{"nctId":318,"briefTitle":319,"status":320,"phases":344,"primaryCompletion":322,"completion":322,"start":52,"enrollment":323,"conditions":345,"interventions":346},[89],[325,28,30,326],[305,328],{"trials":348,"activeCount":97},[],{"intervention":78,"totalTrials":93,"cells":350},{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":369},{"trials":352,"activeCount":97},[],{"trials":354,"activeCount":97},[],{"trials":356,"activeCount":97},[],{"trials":358,"activeCount":97},[],{"trials":360,"activeCount":93,"soonestReadout":77},[361],{"nctId":75,"briefTitle":76,"status":107,"phases":362,"primaryCompletion":77,"completion":363,"start":364,"enrollment":365,"conditions":366,"interventions":368},[89],"2027-08-02","2024-08-05",45,[367],"Solid Organ Transplant",[78],{"trials":370,"activeCount":97},[],{"intervention":372,"totalTrials":373,"cells":374},"Dexmedetomidine",2,{"EARLY_PHASE1":375,"PHASE1":377,"PHASE2":379,"PHASE3":381,"PHASE4":393,"NA":408},{"trials":376,"activeCount":97},[],{"trials":378,"activeCount":97},[],{"trials":380,"activeCount":97},[],{"trials":382,"activeCount":93,"soonestReadout":42},[383],{"nctId":40,"briefTitle":41,"status":192,"phases":384,"primaryCompletion":42,"completion":52,"start":385,"enrollment":386,"conditions":387,"interventions":391},[88],"2017-08-10",450,[388,389,390],"Anesthesia","Neurotoxicity","Child Development",[43,392,372],"Remifentanil",{"trials":394,"activeCount":97},[395],{"nctId":396,"briefTitle":397,"status":398,"phases":399,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":405},"NCT02353182","The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.","COMPLETED",[89],"2016-09","2015-05",60,[404],"Surgical Procedures, Operative",[372,392,406,407],"Bupivacaine","Ropivacaine",{"trials":409,"activeCount":97},[],{"intervention":392,"totalTrials":373,"cells":411},{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":418,"PHASE4":424,"NA":430},{"trials":413,"activeCount":97},[],{"trials":415,"activeCount":97},[],{"trials":417,"activeCount":97},[],{"trials":419,"activeCount":93,"soonestReadout":42},[420],{"nctId":40,"briefTitle":41,"status":192,"phases":421,"primaryCompletion":42,"completion":52,"start":385,"enrollment":386,"conditions":422,"interventions":423},[88],[388,389,390],[43,392,372],{"trials":425,"activeCount":97},[426],{"nctId":396,"briefTitle":397,"status":398,"phases":427,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":428,"interventions":429},[89],[404],[372,392,406,407],{"trials":431,"activeCount":97},[],{"intervention":38,"totalTrials":373,"cells":433},{"EARLY_PHASE1":434,"PHASE1":436,"PHASE2":438,"PHASE3":440,"PHASE4":463,"NA":465},{"trials":435,"activeCount":97},[],{"trials":437,"activeCount":97},[],{"trials":439,"activeCount":97},[],{"trials":441,"activeCount":93,"soonestReadout":37},[442,455],{"nctId":443,"briefTitle":444,"status":445,"phases":446,"primaryCompletion":447,"completion":448,"start":449,"enrollment":97,"conditions":450,"interventions":451},"NCT05543356","COVID-19 Fourth Dose Study in Australia","WITHDRAWN",[88],"2022-07-25","2022-11-30","2022-05-02",[15],[452,453,452,453,454,38,454,38],"Tozinameran","Elasomeran","Bivalent Pfizer-BioNTech",{"nctId":35,"briefTitle":36,"status":192,"phases":456,"primaryCompletion":37,"completion":457,"start":458,"enrollment":459,"conditions":460,"interventions":461},[88],"2026-04","2023-02-28",496,[15],[38,462],"Novavax",{"trials":464,"activeCount":97},[],{"trials":466,"activeCount":97},[],{"intervention":462,"totalTrials":93,"cells":468},{"EARLY_PHASE1":469,"PHASE1":471,"PHASE2":473,"PHASE3":475,"PHASE4":481,"NA":483},{"trials":470,"activeCount":97},[],{"trials":472,"activeCount":97},[],{"trials":474,"activeCount":97},[],{"trials":476,"activeCount":93,"soonestReadout":37},[477],{"nctId":35,"briefTitle":36,"status":192,"phases":478,"primaryCompletion":37,"completion":457,"start":458,"enrollment":459,"conditions":479,"interventions":480},[88],[15],[38,462],{"trials":482,"activeCount":97},[],{"trials":484,"activeCount":97},[],{"intervention":43,"totalTrials":93,"cells":486},{"EARLY_PHASE1":487,"PHASE1":489,"PHASE2":491,"PHASE3":493,"PHASE4":499,"NA":501},{"trials":488,"activeCount":97},[],{"trials":490,"activeCount":97},[],{"trials":492,"activeCount":97},[],{"trials":494,"activeCount":93,"soonestReadout":42},[495],{"nctId":40,"briefTitle":41,"status":192,"phases":496,"primaryCompletion":42,"completion":52,"start":385,"enrollment":386,"conditions":497,"interventions":498},[88],[388,389,390],[43,392,372],{"trials":500,"activeCount":97},[],{"trials":502,"activeCount":97},[],{"intervention":53,"totalTrials":93,"cells":504},{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":519,"PHASE4":521,"NA":523},{"trials":506,"activeCount":97},[],{"trials":508,"activeCount":97},[],{"trials":510,"activeCount":93,"soonestReadout":52},[511],{"nctId":50,"briefTitle":51,"status":192,"phases":512,"primaryCompletion":52,"completion":52,"start":513,"enrollment":514,"conditions":515,"interventions":518},[87],"2025-06-24",120,[516,517],"Scabies; Itch","Scabies",[53],{"trials":520,"activeCount":97},[],{"trials":522,"activeCount":97},[],{"trials":524,"activeCount":97},[],{"intervention":63,"totalTrials":93,"cells":526},{"EARLY_PHASE1":527,"PHASE1":529,"PHASE2":531,"PHASE3":541,"PHASE4":543,"NA":545},{"trials":528,"activeCount":97},[],{"trials":530,"activeCount":97},[],{"trials":532,"activeCount":93,"soonestReadout":62},[533],{"nctId":60,"briefTitle":61,"status":107,"phases":534,"primaryCompletion":62,"completion":67,"start":535,"enrollment":536,"conditions":537,"interventions":539},[86,87],"2024-02-19",10,[538],"Palliative Care",[63,540],"Medicinal Cannabis - C20T5",{"trials":542,"activeCount":97},[],{"trials":544,"activeCount":97},[],{"trials":546,"activeCount":97},[],{"intervention":540,"totalTrials":93,"cells":548},{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":559,"PHASE4":561,"NA":563},{"trials":550,"activeCount":97},[],{"trials":552,"activeCount":97},[],{"trials":554,"activeCount":93,"soonestReadout":62},[555],{"nctId":60,"briefTitle":61,"status":107,"phases":556,"primaryCompletion":62,"completion":67,"start":535,"enrollment":536,"conditions":557,"interventions":558},[86,87],[538],[63,540],{"trials":560,"activeCount":97},[],{"trials":562,"activeCount":97},[],{"trials":564,"activeCount":97},[],{"intervention":566,"totalTrials":93,"cells":567},"Standard dosing of IV ganciclovir",{"EARLY_PHASE1":568,"PHASE1":570,"PHASE2":572,"PHASE3":584,"PHASE4":586,"NA":588},{"trials":569,"activeCount":97},[],{"trials":571,"activeCount":97},[],{"trials":573,"activeCount":93,"soonestReadout":322},[574],{"nctId":575,"briefTitle":576,"status":107,"phases":577,"primaryCompletion":322,"completion":194,"start":578,"enrollment":579,"conditions":580,"interventions":582},"NCT06574789","Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)",[87],"2024-10-29",232,[581],"Cytomegalovirus Viraemia",[566,583],"Personalised dosing of IV ganciclovir",{"trials":585,"activeCount":97},[],{"trials":587,"activeCount":97},[],{"trials":589,"activeCount":97},[],{"intervention":583,"totalTrials":93,"cells":591},{"EARLY_PHASE1":592,"PHASE1":594,"PHASE2":596,"PHASE3":602,"PHASE4":604,"NA":606},{"trials":593,"activeCount":97},[],{"trials":595,"activeCount":97},[],{"trials":597,"activeCount":93,"soonestReadout":322},[598],{"nctId":575,"briefTitle":576,"status":107,"phases":599,"primaryCompletion":322,"completion":194,"start":578,"enrollment":579,"conditions":600,"interventions":601},[87],[581],[566,583],{"trials":603,"activeCount":97},[],{"trials":605,"activeCount":97},[],{"trials":607,"activeCount":97},[],{"intervention":73,"totalTrials":93,"cells":609},{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":642,"PHASE4":644,"NA":646},{"trials":611,"activeCount":97},[],{"trials":613,"activeCount":97},[],{"trials":615,"activeCount":93,"soonestReadout":72},[616],{"nctId":70,"briefTitle":71,"status":107,"phases":617,"primaryCompletion":72,"completion":618,"start":619,"enrollment":620,"conditions":621,"interventions":640},[87],"2027-05","2024-09-13",50,[622,623,624,625,626,627,628,629,630,631,632,633,634,635,636,637,638,639],"Slow-Flow Vascular Malformation","Fast-Flow Vascular Malformation","Vascular Malformations","Venous Malformation","Lymphatic Malformation, Low Flow","Lymphatic Malformation","Lymphangioma","Arteriovenous Malformations","Venous Malformation, Low Flow","Cystic Hygroma","Vascular Anomaly","Vascular Anomalies","PI3K Gene Mutation","MAP2K1 Gene Mutation","PIK3CA-related Overgrowth Spectrum","Arteriovenous Malformation (AVM)","KRAS G12C","KRAS G12D",[73,641],"Mirdametinib",{"trials":643,"activeCount":97},[],{"trials":645,"activeCount":97},[],{"trials":647,"activeCount":97},[],{"intervention":641,"totalTrials":93,"cells":649},{"EARLY_PHASE1":650,"PHASE1":652,"PHASE2":654,"PHASE3":660,"PHASE4":662,"NA":664},{"trials":651,"activeCount":97},[],{"trials":653,"activeCount":97},[],{"trials":655,"activeCount":93,"soonestReadout":72},[656],{"nctId":70,"briefTitle":71,"status":107,"phases":657,"primaryCompletion":72,"completion":618,"start":619,"enrollment":620,"conditions":658,"interventions":659},[87],[622,623,624,625,626,627,628,629,630,631,632,633,634,635,636,637,638,639],[73,641],{"trials":661,"activeCount":97},[],{"trials":663,"activeCount":97},[],{"trials":665,"activeCount":97},[],{"intervention":58,"totalTrials":93,"cells":667},{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":669,"activeCount":97},[],{"trials":671,"activeCount":93,"soonestReadout":57},[672],{"nctId":55,"briefTitle":56,"status":107,"phases":673,"primaryCompletion":57,"completion":57,"start":674,"enrollment":536,"conditions":675,"interventions":678},[86],"2025-07-22",[676,677],"Hodgkin Lymphoma","Non Hodgkin Lymphoma",[58,679],"Dextromethorphan",{"trials":681,"activeCount":97},[],{"trials":683,"activeCount":97},[],{"trials":685,"activeCount":97},[],{"trials":687,"activeCount":97},[],{"intervention":679,"totalTrials":93,"cells":689},{"EARLY_PHASE1":690,"PHASE1":692,"PHASE2":698,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":691,"activeCount":97},[],{"trials":693,"activeCount":93,"soonestReadout":57},[694],{"nctId":55,"briefTitle":56,"status":107,"phases":695,"primaryCompletion":57,"completion":57,"start":674,"enrollment":536,"conditions":696,"interventions":697},[86],[676,677],[58,679],{"trials":699,"activeCount":97},[],{"trials":701,"activeCount":97},[],{"trials":703,"activeCount":97},[],{"trials":705,"activeCount":97},[],{"intervention":452,"totalTrials":373,"cells":707},{"EARLY_PHASE1":708,"PHASE1":710,"PHASE2":712,"PHASE3":714,"PHASE4":720,"NA":733},{"trials":709,"activeCount":97},[],{"trials":711,"activeCount":97},[],{"trials":713,"activeCount":97},[],{"trials":715,"activeCount":97},[716],{"nctId":443,"briefTitle":444,"status":445,"phases":717,"primaryCompletion":447,"completion":448,"start":449,"enrollment":97,"conditions":718,"interventions":719},[88],[15],[452,453,452,453,454,38,454,38],{"trials":721,"activeCount":97},[722],{"nctId":723,"briefTitle":724,"status":398,"phases":725,"primaryCompletion":726,"completion":726,"start":727,"enrollment":728,"conditions":729,"interventions":732},"NCT05168709","Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction",[89],"2022-09-29","2022-01-20",51,[15,730,731],"Vaccine Reaction","Immunization; Infection",[452],{"trials":734,"activeCount":97},[],{"intervention":736,"totalTrials":93,"cells":737},"Stoss vitamin D",{"EARLY_PHASE1":738,"PHASE1":740,"PHASE2":742,"PHASE3":744,"PHASE4":746,"NA":762},{"trials":739,"activeCount":97},[],{"trials":741,"activeCount":97},[],{"trials":743,"activeCount":97},[],{"trials":745,"activeCount":97},[],{"trials":747,"activeCount":97},[748],{"nctId":749,"briefTitle":750,"status":751,"phases":752,"primaryCompletion":753,"completion":753,"start":754,"enrollment":755,"conditions":756,"interventions":758},"NCT03257215","Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study","TERMINATED",[89],"2025-01-30","2017-10-16",13,[757],"Atopic Dermatitis",[736,759,760,761],"Daily vitamin D","Stoss placebo","Daily placebo",{"trials":763,"activeCount":97},[],{"intervention":759,"totalTrials":93,"cells":765},{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":774,"NA":780},{"trials":767,"activeCount":97},[],{"trials":769,"activeCount":97},[],{"trials":771,"activeCount":97},[],{"trials":773,"activeCount":97},[],{"trials":775,"activeCount":97},[776],{"nctId":749,"briefTitle":750,"status":751,"phases":777,"primaryCompletion":753,"completion":753,"start":754,"enrollment":755,"conditions":778,"interventions":779},[89],[757],[736,759,760,761],{"trials":781,"activeCount":97},[],{"intervention":760,"totalTrials":93,"cells":783},{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":792,"NA":798},{"trials":785,"activeCount":97},[],{"trials":787,"activeCount":97},[],{"trials":789,"activeCount":97},[],{"trials":791,"activeCount":97},[],{"trials":793,"activeCount":97},[794],{"nctId":749,"briefTitle":750,"status":751,"phases":795,"primaryCompletion":753,"completion":753,"start":754,"enrollment":755,"conditions":796,"interventions":797},[89],[757],[736,759,760,761],{"trials":799,"activeCount":97},[],{"intervention":761,"totalTrials":93,"cells":801},{"EARLY_PHASE1":802,"PHASE1":804,"PHASE2":806,"PHASE3":808,"PHASE4":810,"NA":816},{"trials":803,"activeCount":97},[],{"trials":805,"activeCount":97},[],{"trials":807,"activeCount":97},[],{"trials":809,"activeCount":97},[],{"trials":811,"activeCount":97},[812],{"nctId":749,"briefTitle":750,"status":751,"phases":813,"primaryCompletion":753,"completion":753,"start":754,"enrollment":755,"conditions":814,"interventions":815},[89],[757],[736,759,760,761],{"trials":817,"activeCount":97},[],{"intervention":819,"totalTrials":93,"cells":820},"Mometasone Furoate 50mcg Nasal Spray",{"EARLY_PHASE1":821,"PHASE1":823,"PHASE2":825,"PHASE3":827,"PHASE4":829,"NA":847},{"trials":822,"activeCount":97},[],{"trials":824,"activeCount":97},[],{"trials":826,"activeCount":97},[],{"trials":828,"activeCount":97},[],{"trials":830,"activeCount":97},[831],{"nctId":832,"briefTitle":833,"status":398,"phases":834,"primaryCompletion":835,"completion":835,"start":836,"enrollment":837,"conditions":838,"interventions":845},"NCT05382494","Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children",[89],"2025-07-17","2022-12-05",130,[839,840,841,842,843,844],"Sleep Disorder; Breathing-Related","Snoring","Obstructive Sleep Apnea of Child","Sleep Disorders in Children","Tonsillar Hypertrophy","Adenoidal Disorder",[819,846],"Sodium Chloride 0.9 % Nasal Spray",{"trials":848,"activeCount":97},[],{"intervention":846,"totalTrials":93,"cells":850},{"EARLY_PHASE1":851,"PHASE1":853,"PHASE2":855,"PHASE3":857,"PHASE4":859,"NA":865},{"trials":852,"activeCount":97},[],{"trials":854,"activeCount":97},[],{"trials":856,"activeCount":97},[],{"trials":858,"activeCount":97},[],{"trials":860,"activeCount":97},[861],{"nctId":832,"briefTitle":833,"status":398,"phases":862,"primaryCompletion":835,"completion":835,"start":836,"enrollment":837,"conditions":863,"interventions":864},[89],[839,840,841,842,843,844],[819,846],{"trials":866,"activeCount":97},[],{"intervention":868,"totalTrials":93,"cells":869},"Montelukast",{"EARLY_PHASE1":870,"PHASE1":872,"PHASE2":874,"PHASE3":876,"PHASE4":878,"NA":888},{"trials":871,"activeCount":97},[],{"trials":873,"activeCount":97},[],{"trials":875,"activeCount":97},[],{"trials":877,"activeCount":97},[],{"trials":879,"activeCount":97},[880],{"nctId":881,"briefTitle":882,"status":398,"phases":883,"primaryCompletion":884,"completion":884,"start":885,"enrollment":402,"conditions":886,"interventions":887},"NCT02534467","Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?",[89],"2018-12-04","2015-07-09",[26],[868],{"trials":889,"activeCount":97},[],{"intervention":891,"totalTrials":93,"cells":892},"Vancomycin - model-based dosing regimen",{"EARLY_PHASE1":893,"PHASE1":895,"PHASE2":897,"PHASE3":899,"PHASE4":901,"NA":913},{"trials":894,"activeCount":97},[],{"trials":896,"activeCount":97},[],{"trials":898,"activeCount":97},[],{"trials":900,"activeCount":97},[],{"trials":902,"activeCount":97},[903],{"nctId":904,"briefTitle":905,"status":398,"phases":906,"primaryCompletion":907,"completion":908,"start":909,"enrollment":910,"conditions":911,"interventions":912},"NCT04044703","Improving Dosing of Vancomycin in Young Infants With Infections",[89],"2020-12-29","2021-01-03","2019-08-30",44,[18,21,32],[891],{"trials":914,"activeCount":97},[],{"intervention":916,"totalTrials":93,"cells":917},"Gardasil®, Merck",{"EARLY_PHASE1":918,"PHASE1":920,"PHASE2":922,"PHASE3":924,"PHASE4":926,"NA":938},{"trials":919,"activeCount":97},[],{"trials":921,"activeCount":97},[],{"trials":923,"activeCount":97},[],{"trials":925,"activeCount":97},[],{"trials":927,"activeCount":97},[928],{"nctId":929,"briefTitle":930,"status":398,"phases":931,"primaryCompletion":932,"completion":932,"start":933,"enrollment":934,"conditions":935,"interventions":937},"NCT04590521","HPV Vaccine Immunity in High-risk Women",[89],"2023-04-19","2022-09-14",63,[936],"HPV Infection",[916],{"trials":939,"activeCount":97},[],{"intervention":406,"totalTrials":93,"cells":941},{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":946,"PHASE3":948,"PHASE4":950,"NA":956},{"trials":943,"activeCount":97},[],{"trials":945,"activeCount":97},[],{"trials":947,"activeCount":97},[],{"trials":949,"activeCount":97},[],{"trials":951,"activeCount":97},[952],{"nctId":396,"briefTitle":397,"status":398,"phases":953,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":954,"interventions":955},[89],[404],[372,392,406,407],{"trials":957,"activeCount":97},[],{"intervention":407,"totalTrials":93,"cells":959},{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":974},{"trials":961,"activeCount":97},[],{"trials":963,"activeCount":97},[],{"trials":965,"activeCount":97},[],{"trials":967,"activeCount":97},[],{"trials":969,"activeCount":97},[970],{"nctId":396,"briefTitle":397,"status":398,"phases":971,"primaryCompletion":400,"completion":400,"start":401,"enrollment":402,"conditions":972,"interventions":973},[89],[404],[372,392,406,407],{"trials":975,"activeCount":97},[],{"intervention":977,"totalTrials":93,"cells":978},"Piperacillin and Tazobactam for",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":987,"NA":1004},{"trials":980,"activeCount":97},[],{"trials":982,"activeCount":97},[],{"trials":984,"activeCount":97},[],{"trials":986,"activeCount":97},[],{"trials":988,"activeCount":97},[989],{"nctId":990,"briefTitle":991,"status":398,"phases":992,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":996,"interventions":998},"NCT04948463","Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia",[89],"2025-12-17","2021-11-15",55,[997],"Febrile Neutropenia",[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],"Cefepime","Ceftazidime","Vancomycin","Amikacin","Ciprofloxacin",{"trials":1005,"activeCount":97},[],{"intervention":999,"totalTrials":93,"cells":1007},{"EARLY_PHASE1":1008,"PHASE1":1010,"PHASE2":1012,"PHASE3":1014,"PHASE4":1016,"NA":1022},{"trials":1009,"activeCount":97},[],{"trials":1011,"activeCount":97},[],{"trials":1013,"activeCount":97},[],{"trials":1015,"activeCount":97},[],{"trials":1017,"activeCount":97},[1018],{"nctId":990,"briefTitle":991,"status":398,"phases":1019,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":1020,"interventions":1021},[89],[997],[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],{"trials":1023,"activeCount":97},[],{"intervention":1000,"totalTrials":93,"cells":1025},{"EARLY_PHASE1":1026,"PHASE1":1028,"PHASE2":1030,"PHASE3":1032,"PHASE4":1034,"NA":1040},{"trials":1027,"activeCount":97},[],{"trials":1029,"activeCount":97},[],{"trials":1031,"activeCount":97},[],{"trials":1033,"activeCount":97},[],{"trials":1035,"activeCount":97},[1036],{"nctId":990,"briefTitle":991,"status":398,"phases":1037,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":1038,"interventions":1039},[89],[997],[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],{"trials":1041,"activeCount":97},[],{"intervention":1001,"totalTrials":93,"cells":1043},{"EARLY_PHASE1":1044,"PHASE1":1046,"PHASE2":1048,"PHASE3":1050,"PHASE4":1052,"NA":1058},{"trials":1045,"activeCount":97},[],{"trials":1047,"activeCount":97},[],{"trials":1049,"activeCount":97},[],{"trials":1051,"activeCount":97},[],{"trials":1053,"activeCount":97},[1054],{"nctId":990,"briefTitle":991,"status":398,"phases":1055,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":1056,"interventions":1057},[89],[997],[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],{"trials":1059,"activeCount":97},[],{"intervention":1002,"totalTrials":93,"cells":1061},{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1068,"PHASE4":1070,"NA":1076},{"trials":1063,"activeCount":97},[],{"trials":1065,"activeCount":97},[],{"trials":1067,"activeCount":97},[],{"trials":1069,"activeCount":97},[],{"trials":1071,"activeCount":97},[1072],{"nctId":990,"briefTitle":991,"status":398,"phases":1073,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":1074,"interventions":1075},[89],[997],[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],{"trials":1077,"activeCount":97},[],{"intervention":1003,"totalTrials":93,"cells":1079},{"EARLY_PHASE1":1080,"PHASE1":1082,"PHASE2":1084,"PHASE3":1086,"PHASE4":1088,"NA":1094},{"trials":1081,"activeCount":97},[],{"trials":1083,"activeCount":97},[],{"trials":1085,"activeCount":97},[],{"trials":1087,"activeCount":97},[],{"trials":1089,"activeCount":97},[1090],{"nctId":990,"briefTitle":991,"status":398,"phases":1091,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":1092,"interventions":1093},[89],[997],[977,999,1000,1001,1002,1003,977,999,1000,1001,1002,1003],{"trials":1095,"activeCount":97},[],{"intervention":1097,"totalTrials":373,"cells":1098},"Tozinameran - Standard Dose",{"EARLY_PHASE1":1099,"PHASE1":1101,"PHASE2":1103,"PHASE3":1105,"PHASE4":1128,"NA":1130},{"trials":1100,"activeCount":97},[],{"trials":1102,"activeCount":97},[],{"trials":1104,"activeCount":97},[],{"trials":1106,"activeCount":97},[1107,1118],{"nctId":1108,"briefTitle":1109,"status":398,"phases":1110,"primaryCompletion":1111,"completion":1112,"start":1113,"enrollment":1114,"conditions":1115,"interventions":1116},"NCT05265065","Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.",[88],"2022-09-30","2024-11-06","2022-05-27",601,[15],[1097,1117],"Tozinameran - Fractional Dose",{"nctId":1119,"briefTitle":1120,"status":751,"phases":1121,"primaryCompletion":447,"completion":448,"start":449,"enrollment":755,"conditions":1122,"interventions":1123},"NCT05228730","Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).",[88],[15],[1124,1125,1126,1127],"Tozinameran - Standard dose","Tozinameran - fractional dose","Elasomeran - standard dose","Elasomeran - fractional dose",{"trials":1129,"activeCount":97},[],{"trials":1131,"activeCount":97},[],{"intervention":1117,"totalTrials":373,"cells":1133},{"EARLY_PHASE1":1134,"PHASE1":1136,"PHASE2":1138,"PHASE3":1140,"PHASE4":1150,"NA":1152},{"trials":1135,"activeCount":97},[],{"trials":1137,"activeCount":97},[],{"trials":1139,"activeCount":97},[],{"trials":1141,"activeCount":97},[1142,1146],{"nctId":1108,"briefTitle":1109,"status":398,"phases":1143,"primaryCompletion":1111,"completion":1112,"start":1113,"enrollment":1114,"conditions":1144,"interventions":1145},[88],[15],[1097,1117],{"nctId":1119,"briefTitle":1120,"status":751,"phases":1147,"primaryCompletion":447,"completion":448,"start":449,"enrollment":755,"conditions":1148,"interventions":1149},[88],[15],[1124,1125,1126,1127],{"trials":1151,"activeCount":97},[],{"trials":1153,"activeCount":97},[],{"intervention":1155,"totalTrials":93,"cells":1156},"0.9%NaCl",{"EARLY_PHASE1":1157,"PHASE1":1159,"PHASE2":1161,"PHASE3":1163,"PHASE4":1178,"NA":1180},{"trials":1158,"activeCount":97},[],{"trials":1160,"activeCount":97},[],{"trials":1162,"activeCount":97},[],{"trials":1164,"activeCount":97},[1165],{"nctId":1166,"briefTitle":1167,"status":398,"phases":1168,"primaryCompletion":1169,"completion":1113,"start":1170,"enrollment":1171,"conditions":1172,"interventions":1176},"NCT04327206","BCG Vaccination to Protect Healthcare Workers Against COVID-19",[88],"2021-11-10","2020-03-30",6828,[1173,1174,1175,15],"Coronavirus Disease 2019 (COVID-19)","Respiratory Illness","Corona Virus Infection",[1177,1155],"BCG Vaccine",{"trials":1179,"activeCount":97},[],{"trials":1181,"activeCount":97},[],{"intervention":1183,"totalTrials":93,"cells":1184},"Nitric Oxide",{"EARLY_PHASE1":1185,"PHASE1":1187,"PHASE2":1189,"PHASE3":1191,"PHASE4":1205,"NA":1207},{"trials":1186,"activeCount":97},[],{"trials":1188,"activeCount":97},[],{"trials":1190,"activeCount":97},[],{"trials":1192,"activeCount":97},[1193],{"nctId":1194,"briefTitle":1195,"status":398,"phases":1196,"primaryCompletion":1197,"completion":1198,"start":1199,"enrollment":1200,"conditions":1201,"interventions":1204},"NCT03661385","Nitric Oxide During Bypass for Arterial Switch Operation",[88],"2022-03-23","2023-04-23","2018-07-11",300,[1202,1203],"Low Cardiac Output Syndrome","Transposition of Great Vessels",[1183],{"trials":1206,"activeCount":97},[],{"trials":1208,"activeCount":97},[],{"intervention":453,"totalTrials":93,"cells":1210},{"EARLY_PHASE1":1211,"PHASE1":1213,"PHASE2":1215,"PHASE3":1217,"PHASE4":1223,"NA":1225},{"trials":1212,"activeCount":97},[],{"trials":1214,"activeCount":97},[],{"trials":1216,"activeCount":97},[],{"trials":1218,"activeCount":97},[1219],{"nctId":443,"briefTitle":444,"status":445,"phases":1220,"primaryCompletion":447,"completion":448,"start":449,"enrollment":97,"conditions":1221,"interventions":1222},[88],[15],[452,453,452,453,454,38,454,38],{"trials":1224,"activeCount":97},[],{"trials":1226,"activeCount":97},[],{"intervention":454,"totalTrials":93,"cells":1228},{"EARLY_PHASE1":1229,"PHASE1":1231,"PHASE2":1233,"PHASE3":1235,"PHASE4":1241,"NA":1243},{"trials":1230,"activeCount":97},[],{"trials":1232,"activeCount":97},[],{"trials":1234,"activeCount":97},[],{"trials":1236,"activeCount":97},[1237],{"nctId":443,"briefTitle":444,"status":445,"phases":1238,"primaryCompletion":447,"completion":448,"start":449,"enrollment":97,"conditions":1239,"interventions":1240},[88],[15],[452,453,452,453,454,38,454,38],{"trials":1242,"activeCount":97},[],{"trials":1244,"activeCount":97},[],{"intervention":1246,"totalTrials":93,"cells":1247},"Azithromycin 500 mg Oral Tablet x 4",{"EARLY_PHASE1":1248,"PHASE1":1250,"PHASE2":1252,"PHASE3":1254,"PHASE4":1266,"NA":1268},{"trials":1249,"activeCount":97},[],{"trials":1251,"activeCount":97},[],{"trials":1253,"activeCount":97},[],{"trials":1255,"activeCount":97},[1256],{"nctId":1257,"briefTitle":1258,"status":398,"phases":1259,"primaryCompletion":1260,"completion":458,"start":1261,"enrollment":1262,"conditions":1263,"interventions":1265},"NCT03925480","Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial",[88],"2022-05-25","2019-07-01",2110,[1264],"Bacterial Infections",[1246],{"trials":1267,"activeCount":97},[],{"trials":1269,"activeCount":97},[],{"intervention":1271,"totalTrials":93,"cells":1272},"PCV10",{"EARLY_PHASE1":1273,"PHASE1":1275,"PHASE2":1277,"PHASE3":1279,"PHASE4":1293,"NA":1295},{"trials":1274,"activeCount":97},[],{"trials":1276,"activeCount":97},[],{"trials":1278,"activeCount":97},[],{"trials":1280,"activeCount":97},[1281],{"nctId":1282,"briefTitle":1283,"status":398,"phases":1284,"primaryCompletion":1285,"completion":1286,"start":1287,"enrollment":1288,"conditions":1289,"interventions":1291},"NCT01953510","Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam",[87,88],"2016-01-27","2021-11-08","2013-09-30",1400,[1290],"Pneumococcal Vaccines",[1271,1292],"PCV13",{"trials":1294,"activeCount":97},[],{"trials":1296,"activeCount":97},[],{"intervention":1292,"totalTrials":93,"cells":1298},{"EARLY_PHASE1":1299,"PHASE1":1301,"PHASE2":1303,"PHASE3":1305,"PHASE4":1311,"NA":1313},{"trials":1300,"activeCount":97},[],{"trials":1302,"activeCount":97},[],{"trials":1304,"activeCount":97},[],{"trials":1306,"activeCount":97},[1307],{"nctId":1282,"briefTitle":1283,"status":398,"phases":1308,"primaryCompletion":1285,"completion":1286,"start":1287,"enrollment":1288,"conditions":1309,"interventions":1310},[87,88],[1290],[1271,1292],{"trials":1312,"activeCount":97},[],{"trials":1314,"activeCount":97},[],{"intervention":1316,"totalTrials":93,"cells":1317},"BCG",{"EARLY_PHASE1":1318,"PHASE1":1320,"PHASE2":1322,"PHASE3":1324,"PHASE4":1337,"NA":1339},{"trials":1319,"activeCount":97},[],{"trials":1321,"activeCount":97},[],{"trials":1323,"activeCount":97},[],{"trials":1325,"activeCount":97},[1326],{"nctId":1327,"briefTitle":1328,"status":398,"phases":1329,"primaryCompletion":1330,"completion":1331,"start":1332,"enrollment":1333,"conditions":1334,"interventions":1336},"NCT01906853","Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction",[88],"2023-09","2025-02","2013-07",1272,[23,1335,30],"Eczema",[1316],{"trials":1338,"activeCount":97},[],{"trials":1340,"activeCount":97},[],{"intervention":1342,"totalTrials":93,"cells":1343},"unfractionated heparin",{"EARLY_PHASE1":1344,"PHASE1":1346,"PHASE2":1348,"PHASE3":1350,"PHASE4":1363,"NA":1365},{"trials":1345,"activeCount":97},[],{"trials":1347,"activeCount":97},[],{"trials":1349,"activeCount":97},[],{"trials":1351,"activeCount":97},[1352],{"nctId":1353,"briefTitle":1354,"status":398,"phases":1355,"primaryCompletion":1356,"completion":1357,"start":1358,"enrollment":1359,"conditions":1360,"interventions":1361},"NCT05204550","Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children",[87,88],"2024-12-09","2026-04-01","2023-01-30",506,[15],[1342,1362],"0.9%sodium chloride",{"trials":1364,"activeCount":97},[],{"trials":1366,"activeCount":97},[],{"intervention":1362,"totalTrials":93,"cells":1368},{"EARLY_PHASE1":1369,"PHASE1":1371,"PHASE2":1373,"PHASE3":1375,"PHASE4":1381,"NA":1383},{"trials":1370,"activeCount":97},[],{"trials":1372,"activeCount":97},[],{"trials":1374,"activeCount":97},[],{"trials":1376,"activeCount":97},[1377],{"nctId":1353,"briefTitle":1354,"status":398,"phases":1378,"primaryCompletion":1356,"completion":1357,"start":1358,"enrollment":1359,"conditions":1379,"interventions":1380},[87,88],[15],[1342,1362],{"trials":1382,"activeCount":97},[],{"trials":1384,"activeCount":97},[],{"intervention":1386,"totalTrials":93,"cells":1387},"PCV Vaccine",{"EARLY_PHASE1":1388,"PHASE1":1390,"PHASE2":1392,"PHASE3":1394,"PHASE4":1406,"NA":1408},{"trials":1389,"activeCount":97},[],{"trials":1391,"activeCount":97},[],{"trials":1393,"activeCount":97},[],{"trials":1395,"activeCount":97},[1396],{"nctId":1397,"briefTitle":1398,"status":398,"phases":1399,"primaryCompletion":1400,"completion":1400,"start":1401,"enrollment":1402,"conditions":1403,"interventions":1405},"NCT03098628","Trial of Simplified Pneumococcal Vaccination in Vietnam II",[87,88],"2020-06-11","2017-03-08",2501,[1404],"Pneumococcal Vaccine",[1386],{"trials":1407,"activeCount":97},[],{"trials":1409,"activeCount":97},[],{"intervention":1411,"totalTrials":93,"cells":1412},"Licensed quadrivalent HPV vaccine, Gardasil",{"EARLY_PHASE1":1413,"PHASE1":1415,"PHASE2":1417,"PHASE3":1419,"PHASE4":1432,"NA":1434},{"trials":1414,"activeCount":97},[],{"trials":1416,"activeCount":97},[],{"trials":1418,"activeCount":97},[],{"trials":1420,"activeCount":97},[1421],{"nctId":1422,"briefTitle":1423,"status":398,"phases":1424,"primaryCompletion":1425,"completion":1426,"start":1427,"enrollment":1428,"conditions":1429,"interventions":1431},"NCT00964210","Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination",[88],"2010-12","2011-04","2008-03",240,[1430],"Cervical Cancer",[1411],{"trials":1433,"activeCount":97},[],{"trials":1435,"activeCount":97},[],{"intervention":1126,"totalTrials":93,"cells":1437},{"EARLY_PHASE1":1438,"PHASE1":1440,"PHASE2":1442,"PHASE3":1444,"PHASE4":1450,"NA":1452},{"trials":1439,"activeCount":97},[],{"trials":1441,"activeCount":97},[],{"trials":1443,"activeCount":97},[],{"trials":1445,"activeCount":97},[1446],{"nctId":1119,"briefTitle":1120,"status":751,"phases":1447,"primaryCompletion":447,"completion":448,"start":449,"enrollment":755,"conditions":1448,"interventions":1449},[88],[15],[1124,1125,1126,1127],{"trials":1451,"activeCount":97},[],{"trials":1453,"activeCount":97},[],{"intervention":1127,"totalTrials":93,"cells":1455},{"EARLY_PHASE1":1456,"PHASE1":1458,"PHASE2":1460,"PHASE3":1462,"PHASE4":1468,"NA":1470},{"trials":1457,"activeCount":97},[],{"trials":1459,"activeCount":97},[],{"trials":1461,"activeCount":97},[],{"trials":1463,"activeCount":97},[1464],{"nctId":1119,"briefTitle":1120,"status":751,"phases":1465,"primaryCompletion":447,"completion":448,"start":449,"enrollment":755,"conditions":1466,"interventions":1467},[88],[15],[1124,1125,1126,1127],{"trials":1469,"activeCount":97},[],{"trials":1471,"activeCount":97},[],{"intervention":1473,"totalTrials":93,"cells":1474},"Pfizer-BioNTech Standard dose",{"EARLY_PHASE1":1475,"PHASE1":1477,"PHASE2":1479,"PHASE3":1481,"PHASE4":1497,"NA":1499},{"trials":1476,"activeCount":97},[],{"trials":1478,"activeCount":97},[],{"trials":1480,"activeCount":97},[],{"trials":1482,"activeCount":97},[1483],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1486,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1490,"interventions":1491},"NCT05387317","Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)",[88],"2025-01","2025-10","2024-04",[15],[1473,1492,1493,1494,1495,1496],"AstraZeneca Standard dose","Pfizer-BioNTech Fractional dose","AstraZeneca Fractional dose","Moderna Standard dose","Moderna Fractional dose",{"trials":1498,"activeCount":97},[],{"trials":1500,"activeCount":97},[],{"intervention":1492,"totalTrials":93,"cells":1502},{"EARLY_PHASE1":1503,"PHASE1":1505,"PHASE2":1507,"PHASE3":1509,"PHASE4":1515,"NA":1517},{"trials":1504,"activeCount":97},[],{"trials":1506,"activeCount":97},[],{"trials":1508,"activeCount":97},[],{"trials":1510,"activeCount":97},[1511],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1512,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1513,"interventions":1514},[88],[15],[1473,1492,1493,1494,1495,1496],{"trials":1516,"activeCount":97},[],{"trials":1518,"activeCount":97},[],{"intervention":1493,"totalTrials":93,"cells":1520},{"EARLY_PHASE1":1521,"PHASE1":1523,"PHASE2":1525,"PHASE3":1527,"PHASE4":1533,"NA":1535},{"trials":1522,"activeCount":97},[],{"trials":1524,"activeCount":97},[],{"trials":1526,"activeCount":97},[],{"trials":1528,"activeCount":97},[1529],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1530,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1531,"interventions":1532},[88],[15],[1473,1492,1493,1494,1495,1496],{"trials":1534,"activeCount":97},[],{"trials":1536,"activeCount":97},[],{"intervention":1494,"totalTrials":93,"cells":1538},{"EARLY_PHASE1":1539,"PHASE1":1541,"PHASE2":1543,"PHASE3":1545,"PHASE4":1551,"NA":1553},{"trials":1540,"activeCount":97},[],{"trials":1542,"activeCount":97},[],{"trials":1544,"activeCount":97},[],{"trials":1546,"activeCount":97},[1547],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1548,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1549,"interventions":1550},[88],[15],[1473,1492,1493,1494,1495,1496],{"trials":1552,"activeCount":97},[],{"trials":1554,"activeCount":97},[],{"intervention":1495,"totalTrials":93,"cells":1556},{"EARLY_PHASE1":1557,"PHASE1":1559,"PHASE2":1561,"PHASE3":1563,"PHASE4":1569,"NA":1571},{"trials":1558,"activeCount":97},[],{"trials":1560,"activeCount":97},[],{"trials":1562,"activeCount":97},[],{"trials":1564,"activeCount":97},[1565],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1566,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1567,"interventions":1568},[88],[15],[1473,1492,1493,1494,1495,1496],{"trials":1570,"activeCount":97},[],{"trials":1572,"activeCount":97},[],{"intervention":1496,"totalTrials":93,"cells":1574},{"EARLY_PHASE1":1575,"PHASE1":1577,"PHASE2":1579,"PHASE3":1581,"PHASE4":1587,"NA":1589},{"trials":1576,"activeCount":97},[],{"trials":1578,"activeCount":97},[],{"trials":1580,"activeCount":97},[],{"trials":1582,"activeCount":97},[1583],{"nctId":1484,"briefTitle":1485,"status":445,"phases":1584,"primaryCompletion":1487,"completion":1488,"start":1489,"enrollment":97,"conditions":1585,"interventions":1586},[88],[15],[1473,1492,1493,1494,1495,1496],{"trials":1588,"activeCount":97},[],{"trials":1590,"activeCount":97},[],{"intervention":1592,"totalTrials":373,"cells":1593},"Resveratrol",{"EARLY_PHASE1":1594,"PHASE1":1596,"PHASE2":1598,"PHASE3":1618,"PHASE4":1620,"NA":1622},{"trials":1595,"activeCount":97},[],{"trials":1597,"activeCount":97},[],{"trials":1599,"activeCount":97},[1600,1610],{"nctId":1601,"briefTitle":1602,"status":398,"phases":1603,"primaryCompletion":1604,"completion":1604,"start":1605,"enrollment":1606,"conditions":1607,"interventions":1609},"NCT03933163","Micronised Resveratrol as a Treatment for Friedreich Ataxia",[87],"2024-03-28","2019-05-23",25,[1608],"Friedreich Ataxia",[1592],{"nctId":1611,"briefTitle":1612,"status":398,"phases":1613,"primaryCompletion":1614,"completion":1615,"start":1426,"enrollment":11,"conditions":1616,"interventions":1617},"NCT01339884","A Study of Resveratrol as Treatment for Friedreich Ataxia",[86,87],"2012-08","2012-12",[1608],[1592],{"trials":1619,"activeCount":97},[],{"trials":1621,"activeCount":97},[],{"trials":1623,"activeCount":97},[],{"intervention":1625,"totalTrials":93,"cells":1626},"Peanut Oral Powder [PEANUT POWDER]",{"EARLY_PHASE1":1627,"PHASE1":1629,"PHASE2":1631,"PHASE3":1641,"PHASE4":1643,"NA":1645},{"trials":1628,"activeCount":97},[],{"trials":1630,"activeCount":97},[],{"trials":1632,"activeCount":97},[1633],{"nctId":1634,"briefTitle":1635,"status":445,"phases":1636,"primaryCompletion":618,"completion":618,"start":1637,"enrollment":97,"conditions":1638,"interventions":1640},"NCT06297083","Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy",[87],"2024-05",[1639],"Peanut Allergy",[1625],{"trials":1642,"activeCount":97},[],{"trials":1644,"activeCount":97},[],{"trials":1646,"activeCount":97},[],{"intervention":1648,"totalTrials":93,"cells":1649},"Methylphenidate Hydrochloride",{"EARLY_PHASE1":1650,"PHASE1":1652,"PHASE2":1654,"PHASE3":1666,"PHASE4":1668,"NA":1670},{"trials":1651,"activeCount":97},[],{"trials":1653,"activeCount":97},[],{"trials":1655,"activeCount":97},[1656],{"nctId":1657,"briefTitle":1658,"status":398,"phases":1659,"primaryCompletion":1660,"completion":1660,"start":1661,"enrollment":1662,"conditions":1663,"interventions":1665},"NCT05185583","Methylphenidate in Childhood Apraxia of Speech",[87],"2025-10-27","2022-03-14",18,[1664],"Childhood Apraxia of Speech",[1648],{"trials":1667,"activeCount":97},[],{"trials":1669,"activeCount":97},[],{"trials":1671,"activeCount":97},[],{"intervention":1673,"totalTrials":93,"cells":1674},"Cannabidiol Oil",{"EARLY_PHASE1":1675,"PHASE1":1677,"PHASE2":1679,"PHASE3":1693,"PHASE4":1695,"NA":1697},{"trials":1676,"activeCount":97},[],{"trials":1678,"activeCount":97},[],{"trials":1680,"activeCount":97},[1681],{"nctId":1682,"briefTitle":1683,"status":398,"phases":1684,"primaryCompletion":1685,"completion":1686,"start":1687,"enrollment":1688,"conditions":1689,"interventions":1692},"NCT04821856","Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability",[87],"2025-07-09","2025-08-19","2021-05-11",132,[1690,1691],"Intellectual Disability","Child Behavior Problem",[1673],{"trials":1694,"activeCount":97},[],{"trials":1696,"activeCount":97},[],{"trials":1698,"activeCount":97},[],{"intervention":1700,"totalTrials":93,"cells":1701},"Medicinal cannabis (MC): THC 10mg\u002FmL : CBD 15mg\u002FmL, manufactured by Cann Group Ltd.",{"EARLY_PHASE1":1702,"PHASE1":1704,"PHASE2":1706,"PHASE3":1718,"PHASE4":1720,"NA":1722},{"trials":1703,"activeCount":97},[],{"trials":1705,"activeCount":97},[],{"trials":1707,"activeCount":97},[1708],{"nctId":1709,"briefTitle":1710,"status":398,"phases":1711,"primaryCompletion":1712,"completion":1713,"start":1714,"enrollment":536,"conditions":1715,"interventions":1717},"NCT05184478","Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study",[86,87],"2023-12-05","2024-01-04","2022-05-16",[1716],"Tourette Syndrome in Adolescence",[1700],{"trials":1719,"activeCount":97},[],{"trials":1721,"activeCount":97},[],{"trials":1723,"activeCount":97},[],{"intervention":1725,"totalTrials":93,"cells":1726},"RV3-BB",{"EARLY_PHASE1":1727,"PHASE1":1729,"PHASE2":1731,"PHASE3":1743,"PHASE4":1745,"NA":1747},{"trials":1728,"activeCount":97},[],{"trials":1730,"activeCount":97},[],{"trials":1732,"activeCount":97},[1733],{"nctId":1734,"briefTitle":1735,"status":398,"phases":1736,"primaryCompletion":1737,"completion":1737,"start":1738,"enrollment":1739,"conditions":1740,"interventions":1742},"NCT03483116","A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine",[87],"2020-01-27","2018-06-15",711,[1741],"Rotavirus Infections",[1725],{"trials":1744,"activeCount":97},[],{"trials":1746,"activeCount":97},[],{"trials":1748,"activeCount":97},[],{"intervention":1750,"totalTrials":93,"cells":1751},"Autologous Human Placental Cord Blood Mononuclear Cells",{"EARLY_PHASE1":1752,"PHASE1":1754,"PHASE2":1768,"PHASE3":1770,"PHASE4":1772,"NA":1774},{"trials":1753,"activeCount":97},[],{"trials":1755,"activeCount":97},[1756],{"nctId":1757,"briefTitle":1758,"status":398,"phases":1759,"primaryCompletion":1760,"completion":1761,"start":1762,"enrollment":536,"conditions":1763,"interventions":1767},"NCT03431480","Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery",[86],"2021-11-01","2022-06-30","2018-02-16",[1764,1765,1766],"Hypoplastic Left Heart Syndrome","Heart Defects, Congenital","Pediatric Disorder",[1750],{"trials":1769,"activeCount":97},[],{"trials":1771,"activeCount":97},[],{"trials":1773,"activeCount":97},[],{"trials":1775,"activeCount":97},[],{"intervention":1777,"totalTrials":93,"cells":1778},"Matched sibling donor cord blood cell",{"EARLY_PHASE1":1779,"PHASE1":1781,"PHASE2":1794,"PHASE3":1796,"PHASE4":1798,"NA":1800},{"trials":1780,"activeCount":97},[],{"trials":1782,"activeCount":97},[1783],{"nctId":1784,"briefTitle":1785,"status":398,"phases":1786,"primaryCompletion":1787,"completion":1788,"start":1789,"enrollment":1790,"conditions":1791,"interventions":1793},"NCT03087110","Stem Cells in Umbilical Blood Infusion for CP",[86],"2019-09","2020-12","2016-03",12,[1792],"Cerebral Palsy",[1777],{"trials":1795,"activeCount":97},[],{"trials":1797,"activeCount":97},[],{"trials":1799,"activeCount":97},[],{"trials":1801,"activeCount":97},[],{"intervention":1803,"totalTrials":93,"cells":1804},"ivermectin infant formula preparation",{"EARLY_PHASE1":1805,"PHASE1":1807,"PHASE2":1820,"PHASE3":1822,"PHASE4":1824,"NA":1826},{"trials":1806,"activeCount":97},[],{"trials":1808,"activeCount":97},[1809],{"nctId":1810,"briefTitle":1811,"status":1812,"phases":1813,"primaryCompletion":1814,"completion":1815,"start":57,"enrollment":1816,"conditions":1817,"interventions":1818},"NCT06918665","HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation","SUSPENDED",[86],"2027-07-01","2027-08-01",52,[517],[1803,1819],"Standard ivermectin 3mg",{"trials":1821,"activeCount":97},[],{"trials":1823,"activeCount":97},[],{"trials":1825,"activeCount":97},[],{"trials":1827,"activeCount":97},[],{"intervention":1819,"totalTrials":93,"cells":1829},{"EARLY_PHASE1":1830,"PHASE1":1832,"PHASE2":1838,"PHASE3":1840,"PHASE4":1842,"NA":1844},{"trials":1831,"activeCount":97},[],{"trials":1833,"activeCount":97},[1834],{"nctId":1810,"briefTitle":1811,"status":1812,"phases":1835,"primaryCompletion":1814,"completion":1815,"start":57,"enrollment":1816,"conditions":1836,"interventions":1837},[86],[517],[1803,1819],{"trials":1839,"activeCount":97},[],{"trials":1841,"activeCount":97},[],{"trials":1843,"activeCount":97},[],{"trials":1845,"activeCount":97},[],{"intervention":1847,"totalTrials":93,"cells":1848},"Streptococcus pyogenes M1UK strain MCRI0102",{"EARLY_PHASE1":1849,"PHASE1":1863,"PHASE2":1865,"PHASE3":1867,"PHASE4":1869,"NA":1871},{"trials":1850,"activeCount":97},[1851],{"nctId":1852,"briefTitle":1853,"status":398,"phases":1854,"primaryCompletion":1855,"completion":1856,"start":1857,"enrollment":1858,"conditions":1859,"interventions":1862},"NCT06992141","A Strep Throat Controlled Human Infection Trial in Healthy Adults",[85],"2025-10-31","2026-02-16","2025-07-24",40,[1860,1861],"Streptococcus Pyogenes Pharyngitis","Streptococcus Infection",[1847],{"trials":1864,"activeCount":97},[],{"trials":1866,"activeCount":97},[],{"trials":1868,"activeCount":97},[],{"trials":1870,"activeCount":97},[],{"trials":1872,"activeCount":97},[],{"intervention":1177,"totalTrials":373,"cells":1874},{"EARLY_PHASE1":1875,"PHASE1":1877,"PHASE2":1879,"PHASE3":1881,"PHASE4":1887,"NA":1889},{"trials":1876,"activeCount":97},[],{"trials":1878,"activeCount":97},[],{"trials":1880,"activeCount":97},[],{"trials":1882,"activeCount":97},[1883],{"nctId":1166,"briefTitle":1167,"status":398,"phases":1884,"primaryCompletion":1169,"completion":1113,"start":1170,"enrollment":1171,"conditions":1885,"interventions":1886},[88],[1173,1174,1175,15],[1177,1155],{"trials":1888,"activeCount":97},[],{"trials":1890,"activeCount":97},[1891],{"nctId":1892,"briefTitle":1893,"status":398,"phases":1894,"primaryCompletion":1895,"completion":1895,"start":1896,"enrollment":1897,"conditions":1898,"interventions":1900},"NCT02444611","A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study",[90],"2016-06","2015-03",185,[1899],"Innate Immune Response",[1177,1901],"Hepatitis B Vaccine",{"intervention":1901,"totalTrials":93,"cells":1903},{"EARLY_PHASE1":1904,"PHASE1":1906,"PHASE2":1908,"PHASE3":1910,"PHASE4":1912,"NA":1914},{"trials":1905,"activeCount":97},[],{"trials":1907,"activeCount":97},[],{"trials":1909,"activeCount":97},[],{"trials":1911,"activeCount":97},[],{"trials":1913,"activeCount":97},[],{"trials":1915,"activeCount":97},[1916],{"nctId":1892,"briefTitle":1893,"status":398,"phases":1917,"primaryCompletion":1895,"completion":1895,"start":1896,"enrollment":1897,"conditions":1918,"interventions":1919},[90],[1899],[1177,1901],{"intervention":1921,"totalTrials":93,"cells":1922},"Cervarix®",{"EARLY_PHASE1":1923,"PHASE1":1925,"PHASE2":1927,"PHASE3":1929,"PHASE4":1931,"NA":1933},{"trials":1924,"activeCount":97},[],{"trials":1926,"activeCount":97},[],{"trials":1928,"activeCount":97},[],{"trials":1930,"activeCount":97},[],{"trials":1932,"activeCount":97},[],{"trials":1934,"activeCount":97},[1935],{"nctId":1936,"briefTitle":1937,"status":398,"phases":1938,"primaryCompletion":1896,"completion":1896,"start":1939,"enrollment":323,"conditions":1940,"interventions":1942},"NCT02276521","Evaluation of Long Term Immunity Following HPV Vaccination",[],"2015-02",[1430,1941],"Anogenital Warts",[1921],{"intervention":1944,"totalTrials":93,"cells":1945},"ceftriaxone",{"EARLY_PHASE1":1946,"PHASE1":1948,"PHASE2":1950,"PHASE3":1952,"PHASE4":1954,"NA":1956},{"trials":1947,"activeCount":97},[],{"trials":1949,"activeCount":97},[],{"trials":1951,"activeCount":97},[],{"trials":1953,"activeCount":97},[],{"trials":1955,"activeCount":97},[],{"trials":1957,"activeCount":97},[1958],{"nctId":1959,"briefTitle":1960,"status":398,"phases":1961,"primaryCompletion":1962,"completion":1963,"start":1964,"enrollment":1965,"conditions":1966,"interventions":1967},"NCT02334124","Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital",[90],"2017-06","2022-11","2015-01",190,[28],[1944,1968],"flucloxacillin",{"intervention":1968,"totalTrials":93,"cells":1970},{"EARLY_PHASE1":1971,"PHASE1":1973,"PHASE2":1975,"PHASE3":1977,"PHASE4":1979,"NA":1981},{"trials":1972,"activeCount":97},[],{"trials":1974,"activeCount":97},[],{"trials":1976,"activeCount":97},[],{"trials":1978,"activeCount":97},[],{"trials":1980,"activeCount":97},[],{"trials":1982,"activeCount":97},[1983],{"nctId":1959,"briefTitle":1960,"status":398,"phases":1984,"primaryCompletion":1962,"completion":1963,"start":1964,"enrollment":1965,"conditions":1985,"interventions":1986},[90],[28],[1944,1968],{"intervention":1988,"totalTrials":93,"cells":1989},"Continuous infusion of vancomycin",{"EARLY_PHASE1":1990,"PHASE1":1992,"PHASE2":1994,"PHASE3":1996,"PHASE4":1998,"NA":2000},{"trials":1991,"activeCount":97},[],{"trials":1993,"activeCount":97},[],{"trials":1995,"activeCount":97},[],{"trials":1997,"activeCount":97},[],{"trials":1999,"activeCount":97},[],{"trials":2001,"activeCount":97},[2002],{"nctId":2003,"briefTitle":2004,"status":398,"phases":2005,"primaryCompletion":2006,"completion":2007,"start":2008,"enrollment":2009,"conditions":2010,"interventions":2011},"NCT02210169","RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates",[90],"2018-04","2018-05","2014-09",111,[18,21,32],[1988]]